TABLE 4

Skeletal muscle sphingomyelin content (nmol/g tissue) at baseline, after 4-h hyperinsulinemia, and after clamp with Intralipid/heparin infusion (n = 10)

Fatty acidBaselineAfter 4-h clampAfter 4-h clamp with Intralipid/ heparin infusion
n101010
Total1,281.52 ± 182.901,327.93 ± 258.661,479.99 ± 265.89*
Myristic (14:0)38.41 ± 8.3540.52 ± 10.9943.89 ± 17.57
Palmitic (16:0)346.38 ± 57.26387.44 ± 90.60436.51 ± 98.28*
Palmitoleic (16:1)3.01 ± 1.232.58 ± 1.654.47 ± 1.86
Stearic (18:0)400.63 ± 62.39395.75 ± 58.84436.54 ± 74.08*
Oleic (18:1)21.35 ± 3.6025.53 ± 10.1231.52 ± 13.12*
Linoleic (18:2)17.36 ± 4.4421.18 ± 8.8925.10 ± 6.99*
Linolenic (18:3)2.97 ± 3.663.85 ± 3.496.49 ± 7.23*
Arachidic (20:0)34.50 ± 10.4635.06 ± 8.8038.81 ± 9.89
Arachidonic (20:4)11.13 ± 3.0911.79 ± 5.8913.34 ± 4.01
Eicosapentaenoic (20:5)1.60 ± 1.833.05 ± 2.024.28 ± 1.93*
Behenic (22:0)113.96 ± 25.83118.49 ± 27.89131.73 ± 30.35
Docosahexaenoic (22:6)2.91 ± 3.183.86 ± 2.856.23 ± 1.56*
Nervonic (24:1)287.31 ± 70.83278.81 ± 85.57301.10 ± 69.94
  • Data are expressed as means ± SD.

  • *

    * P < 0.05 in comparison to baseline values.